Friday, May 1, 2026

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

IU’s Generosity Shines Again: Treating Her Team to Business Class Seats

IU, widely recognized for her frequent charitable donations, she has recently earned acclaim once more for her generosity.

Tired All the Time? Your Lethargy Might Be More Serious Than You Think

Myasthenia gravis is an autoimmune disorder causing muscle weakness and fatigue, requiring careful diagnosis and lifelong treatment.

Tag: Vostok Intur

No posts to display

Top News

- Our Sponsors Ad -

Follow us